- Conditions
- Surgical Site Infections, Nosocomial Infection, Healthcare Associated Infections
- Interventions
- methylene blue 0.01%/chlorhexidine gluconate 0.25% + light activation
- Combination Product
- Lead sponsor
- Ondine Biomedical Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 322 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022
- U.S. locations
- 1
- States / cities
- Savannah, Georgia
Source: ClinicalTrials.gov public record
Updated Aug 21, 2022 · Synced May 22, 2026, 3:47 AM EDT